Enhanced Therapeutic Efficacy of Doxorubicin for Breast Cancer Using Chitosan Oligosaccharide-Modified Halloysite Nanotubes

ACS Applied Materials and Interfaces

Volumn 8, Issue 40, 2016, Pages 26578-26590

  Yang, Jing ^a   Wu, Yanping ^a   Shen, Yan ^a   Zhou, Changren ^a   Li, Yi Fang ^a   He, Rong Rong ^a   Liu, Mingxian ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

cell viability; drug delivery; nanotube; surface grafting; tumor therapy

Indexed keywords

BIOCOMPATIBILITY; CELL DEATH; CHEMOTHERAPY; CHITIN; CHITOSAN; CYTOLOGY; DISEASES; DRUG DELIVERY; DRUG DOSAGE; ENZYME INHIBITION; GRAFTING (CHEMICAL); KAOLINITE; MAMMALS; NANOTUBES; OLIGOSACCHARIDES; TUMORS; YARN;

CELL VIABILITY; CHITOSAN OLIGOSACCHARIDE; HALLOYSITE NANOTUBE (HNTS); IMPROVED HEMOCOMPATIBILITY; POSITIVELY CHARGED SURFACES; REACTIVE OXYGEN SPECIES; SURFACE GRAFTING; TUMOR THERAPY;

CELLS;

ALUMINUM SILICATE; CHITOSAN; CLAY; DOXORUBICIN; NANOTUBE; OLIGOSACCHARIDE;

ANIMAL; BREAST TUMOR; HUMAN; MOUSE; TUMOR CELL LINE;

ALUMINUM SILICATES; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CHITOSAN; DOXORUBICIN; HUMANS; MICE; NANOTUBES; OLIGOSACCHARIDES;

EID: 84991704893     PISSN: 19448244     EISSN: 19448252     Source Type: Journal    
DOI: 10.1021/acsami.6b09074     Document Type: Article

References (70)

1. Schroeder, A.; Heller, D. A.; Winslow, M. M.; Dahlman, J. E.; Pratt, G. W.; Langer, R.; Jacks, T.; Anderson, D. G. Treating Metastatic Cancer with Nanotechnology Nat. Rev. Cancer 2012, 12, 39-50 10.1038/nrc3180
2. Ferrari, M. Cancer Nanotechnology: Opportunities and Challenges Nat. Rev. Cancer 2005, 5, 161-171 10.1038/nrc1566
3. Eetezadi, S.; Ekdawi, S. N.; Allen, C. The Challenges Facing Block Copolymer Micelles for Cancer Therapy: In Vivo Barriers and Clinical Translation Adv. Drug Delivery Rev. 2015, 91, 7-22 10.1016/j.addr.2014.10.001
4. Liang, X.; Gao, J.; Jiang, L.; Luo, J.; Jing, L.; Li, X.; Jin, Y.; Dai, Z. Nanohybrid Liposomal Cerasomes with Good Physiological Stability and Rapid Temperature Responsiveness for High Intensity Focused Ultrasound Triggered Local Chemotherapy of Cancer ACS Nano 2015, 9, 1280-1293 10.1021/nn507482w
5. Czapar, A. E.; Zheng, Y.-R.; Riddell, I. A.; Shukla, S.; Awuah, S. G.; Lippard, S. J.; Steinmetz, N. F. Tobacco Mosaic Virus Delivery of Phenanthriplatin for Cancer Therapy ACS Nano 2016, 10, 4119-4126 10.1021/acsnano.5b07360
6. He, L.; Lai, H.; Chen, T. Dual-Function Nanosystem for Synergetic Cancer Chemo-/Radiotherapy through ROS-Mediated Signaling Pathways Biomaterials 2015, 51, 30-42 10.1016/j.biomaterials.2015.01.063
7. Orecchioni, M.; Cabizza, R.; Bianco, A.; Delogu, L. G. Graphene as Cancer Theranostic Tool: Progress and Future Challenges Theranostics 2015, 5, 710 10.7150/thno.11387
8. Li, J.; Lyv, Z.; Li, Y.; Liu, H.; Wang, J.; Zhan, W.; Chen, H.; Chen, H.; Li, X. A Theranostic Prodrug Delivery System Based on Pt (IV) Conjugated Nano-Graphene Oxide with Synergistic Effect to Enhance the Therapeutic Efficacy of Pt Drug Biomaterials 2015, 51, 12-21 10.1016/j.biomaterials.2015.01.074
9. Meng, H.; Wang, M.; Liu, H.; Liu, X.; Situ, A.; Wu, B.; Ji, Z.; Chang, C. H.; Nel, A. E. Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice ACS Nano 2015, 9, 3540-3557 10.1021/acsnano.5b00510
10. de la Torre, C.; Casanova, I.; Acosta, G.; Coll, C.; Moreno, M. J.; Albericio, F.; Aznar, E.; Mangues, R.; Royo, M.; Sancenón, F.; Martinez-Manez, R. Gated Mesoporous Silica Nanoparticles Using a Double-Role Circular Peptide for the Controlled and Target-Preferential Release of Doxorubicin in CXCR4-Expresing Lymphoma Cells Adv. Funct. Mater. 2015, 25, 687-695 10.1002/adfm.201403822
11. 4 Nanoparticles Enhances T2MR Imaging of Tumor Apoptosis Nano Lett. 2016, 16, 2686-2691 10.1021/acs.nanolett.6b00331
12. Goldberg, M.; Langer, R.; Jia, X. Nanostructured Materials for Applications in Drug Delivery and Tissue Engineering J. Biomater. Sci., Polym. Ed. 2007, 18, 241-268 10.1163/156856207779996931
13. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an Emerging Platform for Cancer Therapy Nat. Nanotechnol. 2007, 2, 751-760 10.1038/nnano.2007.387
14. Allen, T. M.; Cullis, P. R. Drug Delivery Systems: Entering the Mainstream Science 2004, 303, 1818-1822 10.1126/science.1095833
15. Joussein, E.; Petit, S.; Churchman, J.; Theng, B.; Righi, D.; Delvaux, B. Halloysite Clay Minerals-a Review Clay Miner. 2005, 40, 383-426 10.1180/0009855054040180
16. Lvov, Y. M.; Shchukin, D. G.; Mohwald, H.; Price, R. R. Halloysite Clay Nanotubes for Controlled Release of Protective Agents ACS Nano 2008, 2, 814-820 10.1021/nn800259q
17. Liu, M.; Jia, Z.; Jia, D.; Zhou, C. Recent Advance in Research on Halloysite Nanotubes-Polymer Nanocomposite Prog. Polym. Sci. 2014, 39, 1498-1525 10.1016/j.progpolymsci.2014.04.004
18. Zhao, M.; Liu, P. Adsorption Behavior of Methylene Blue on Halloysite Nanotubes Microporous Mesoporous Mater. 2008, 112, 419-424 10.1016/j.micromeso.2007.10.018
19. Jinhua, W.; Xiang, Z.; Bing, Z.; Yafei, Z.; Rui, Z.; Jindun, L.; Rongfeng, C. Rapid Adsorption of Cr (VI) on Modified Halloysite Nanotubes Desalination 2010, 259, 22-28 10.1016/j.desal.2010.04.046
20. Vergaro, V.; Abdullayev, E.; Lvov, Y. M.; Zeitoun, A.; Cingolani, R.; Rinaldi, R.; Leporatti, S. Cytocompatibility and Uptake of Halloysite Clay Nanotubes Biomacromolecules 2010, 11, 820-826 10.1021/bm9014446
21. Liu, M.; Wu, C.; Jiao, Y.; Xiong, S.; Zhou, C. Chitosan-Halloysite Nanotubes Nanocomposite Scaffolds for Tissue Engineering J. Mater. Chem. B 2013, 1, 2078-2089 10.1039/c3tb20084a
22. Liu, M.; Zhang, Y.; Wu, C.; Xiong, S.; Zhou, C. Chitosan/Halloysite Nanotubes Bionanocomposites: Structure, Mechanical Properties and Biocompatibility Int. J. Biol. Macromol. 2012, 51, 566-575 10.1016/j.ijbiomac.2012.06.022
23. Kryuchkova, M.; Danilushkina, A. A.; Lvov, Y. M.; Fakhrullin, R. F. Evaluation of Toxicity of Nanoclays and Graphene Oxide in Vivo: A Paramecium Caudatum Study Environ. Sci.: Nano 2016, 3, 442-452 10.1039/C5EN00201J
24. Frost, R. L.; Kristof, J. Intercalation of Halloysite: A Raman Spectroscopic Study Clays Clay Miner. 1997, 45, 551-563 10.1346/CCMN.1997.0450407
25. Joo, Y.; Jeon, Y.; Lee, S. U.; Sim, J. H.; Ryu, J.; Lee, S.; Lee, H.; Sohn, D. Aggregation and Stabilization of Carboxylic Acid Functionalized Halloysite Nanotubes (HNT-COOH) J. Phys. Chem. C 2012, 116, 18230-18235 10.1021/jp3038945
26. Lee, Y.; Jung, G.-E.; Cho, S. J.; Geckeler, K. E.; Fuchs, H. Cellular Interactions of Doxorubicin-Loaded DNA-Modified Halloysite Nanotubes Nanoscale 2013, 5, 8577-8585 10.1039/c3nr02665e
27. Riela, S.; Massaro, M.; Colletti, C. G.; Bommarito, A.; Giordano, C.; Milioto, S.; Noto, R.; Poma, P.; Lazzara, G. Development and Characterization of Co-Loaded Curcumin/Triazole-Halloysite Systems and Evaluation of Their Potential Anticancer Activity Int. J. Pharm. 2014, 475, 613-623 10.1016/j.ijpharm.2014.09.019
28. Liu, M.; Chang, Y.; Yang, J.; You, Y.; He, R.; Chen, T.; Zhou, C. Functionalized Halloysite Nanotube by Chitosan Grafting for Drug Delivery of Curcumin to Achieve Enhanced Anticancer Efficacy J. Mater. Chem. B 2016, 4, 2253-2263 10.1039/C5TB02725J
29. Zhai, R.; Zhang, B.; Liu, L.; Xie, Y.; Zhang, H.; Liu, J. Immobilization of Enzyme Biocatalyst on Natural Halloysite Nanotubes Catal. Commun. 2010, 12, 259-263 10.1016/j.catcom.2010.09.030
30. Abdullayev, E.; Lvov, Y. Clay Nanotubes for Corrosion Inhibitor Encapsulation: Release Control with End Stoppers J. Mater. Chem. 2010, 20, 6681-6687 10.1039/c0jm00810a
31. Veerabadran, N. G.; Mongayt, D.; Torchilin, V.; Price, R. R.; Lvov, Y. M. Organized Shells on Clay Nanotubes for Controlled Release of Macromolecules Macromol. Rapid Commun. 2009, 30, 99-103 10.1002/marc.200800510
32. Fu, Y.; Zhao, D.; Yao, P.; Wang, W.; Zhang, L.; Lvov, Y. Highly Aging-Resistant Elastomers Doped with Antioxidant-Loaded Clay Nanotubes ACS Appl. Mater. Interfaces 2015, 7, 8156-8165 10.1021/acsami.5b00993
33. Abdullayev, E.; Lvov, Y. Halloysite Clay Nanotubes as a Ceramic "Skeleton" for Functional Biopolymer Composites with Sustained Drug Release J. Mater. Chem. B 2013, 1, 2894-2903 10.1039/c3tb20059k
34. Jing, H.; Higaki, Y.; Ma, W.; Wu, H.; Yah, W. O.; Otsuka, H.; Lvov, Y. M.; Takahara, A. Internally Modified Halloysite Nanotubes as Inorganic Nanocontainers for a Flame Retardant Chem. Lett. 2013, 42, 121-123 10.1246/cl.2013.121
35. Abdullayev, E.; Price, R.; Shchukin, D.; Lvov, Y. Halloysite Tubes as Nanocontainers for Anticorrosion Coating with Benzotriazole ACS Appl. Mater. Interfaces 2009, 1, 1437-1443 10.1021/am9002028
36. Yuan, P.; Southon, P. D.; Liu, Z.; Kepert, C. J. Organosilane Functionalization of Halloysite Nanotubes for Enhanced Loading and Controlled Release Nanotechnology 2012, 23, 375705 10.1088/0957-4484/23/37/375705
37. Qi, R.; Guo, R.; Shen, M.; Cao, X.; Zhang, L.; Xu, J.; Yu, J.; Shi, X. Electrospun Poly (Lactic-Co-Glycolic Acid)/Halloysite Nanotube Composite Nanofibers for Drug Encapsulation and Sustained Release J. Mater. Chem. 2010, 20, 10622-10629 10.1039/c0jm01328e
38. Shi, Y.-F.; Tian, Z.; Zhang, Y.; Shen, H.-B.; Jia, N.-Q. Functionalized Halloysite Nanotube-Based Carrier for Intracellular Delivery of Antisense Oligonucleotides Nanoscale Res. Lett. 2011, 6, 608 10.1186/1556-276X-6-608
39. Gautier, J.; Allard-Vannier, E.; Munnier, E.; Soucé, M.; Chourpa, I. Recent Advances in Theranostic Nanocarriers of Doxorubicin Based on Iron Oxide and Gold Nanoparticles J. Controlled Release 2013, 169, 48-61 10.1016/j.jconrel.2013.03.018
40. Wang, Y.; Zhang, X.; Yu, P.; Li, C. Glycopolymer Micelles with Reducible Ionic Cores for Hepatocytes-Targeting Delivery of DOX Int. J. Pharm. 2013, 441, 170-180 10.1016/j.ijpharm.2012.12.001
41. Tacar, O.; Sriamornsak, P.; Dass, C. R. Doxorubicin: An Update on Anticancer Molecular Action, Toxicity and Novel Drug Delivery Systems J. Pharm. Pharmacol. 2013, 65, 157-170 10.1111/j.2042-7158.2012.01567.x
42. Huan, M.; Zhang, B.; Teng, Z.; Cui, H.; Wang, J.; Liu, X.; Xia, H.; Zhou, S.; Mei, Q. In Vitro and in Vivo Antitumor Activity of a Novel Ph-Activated Polymeric Drug Delivery System for Doxorubicin PLoS One 2012, 7, e44116 10.1371/journal.pone.0044116
43. Longhi, A.; Ferrari, S.; Bacci, G.; Specchia, S. Long-Term Follow-up of Patients with Doxorubicin-Induced Cardiac Toxicity after Chemotherapy for Osteosarcoma Anti-Cancer Drugs 2007, 18, 737-744 10.1097/CAD.0b013e32803d36fe
44. Granados-Principal, S.; El-azem, N.; Pamplona, R.; Ramirez-Tortosa, C.; Pulido-Moran, M.; Vera-Ramirez, L.; Quiles, J. L.; Sanchez-Rovira, P.; Naudí, A.; Portero-Otin, M.; Perez-Lopez, P.; Ramirez-Tortosa, M. Hydroxytyrosol Ameliorates Oxidative Stress and Mitochondrial Dysfunction in Doxorubicin-Induced Cardiotoxicity in Rats with Breast Cancer Biochem. Pharmacol. 2014, 90, 25-33 10.1016/j.bcp.2014.04.001
45. Hilmer, S. N.; Cogger, V. C.; Muller, M.; Le Couteur, D. G. The Hepatic Pharmacokinetics of Doxorubicin and Liposomal Doxorubicin Drug Metab. Dispos. 2004, 32, 794-799 10.1124/dmd.32.8.794
46. Ke, X.-Y.; Ng, V. W. L.; Gao, S.-J.; Tong, Y. W.; Hedrick, J. L.; Yang, Y. Y. Co-Delivery of Thioridazine and Doxorubicin Using Polymeric Micelles for Targeting Both Cancer Cells and Cancer Stem Cells Biomaterials 2014, 35, 1096-1108 10.1016/j.biomaterials.2013.10.049
47. 64Cu-Labeled Superparamagnetic Iron Oxide Nanoparticles for Targeted Anticancer Drug Delivery and PET/MR Imaging Biomaterials 2011, 32, 4151-4160 10.1016/j.biomaterials.2011.02.006
48. Xiong, H.; Du, S.; Ni, J.; Zhou, J.; Yao, J. Mitochondria and Nuclei Dual-Targeted Heterogeneous Hydroxyapatite Nanoparticles for Enhancing Therapeutic Efficacy of Doxorubicin Biomaterials 2016, 94, 70-83 10.1016/j.biomaterials.2016.04.004
49. Li, L.; Fan, H.; Wang, L.; Jin, Z. Does Halloysite Behave Like an Inert Carrier for Doxorubicin? RSC Adv. 2016, 6, 54193-54201 10.1039/C6RA09198A
50. Kostarelos, K.; Lacerda, L.; Pastorin, G.; Wu, W.; Wieckowski, S.; Luangsivilay, J.; Godefroy, S.; Pantarotto, D.; Briand, J.-P.; Muller, S.; Prato, M.; Bianco, A. Cellular Uptake of Functionalized Carbon Nanotubes Is Independent of Functional Group and Cell Type Nat. Nanotechnol. 2007, 2, 108-113 10.1038/nnano.2006.209
51. Rong, R.; Xu, X.; Zhu, S.; Li, B.; Wang, X.; Tang, K. Facile Preparation of Homogeneous and Length Controllable Halloysite Nanotubes by Ultrasonic Scission and Uniform Viscosity Centrifugation Chem. Eng. J. 2016, 291, 20-29 10.1016/j.cej.2016.01.082
52. Veerabadran, N. G.; Price, R. R.; Lvov, Y. M. Clay Nanotubes for Encapsulation and Sustained Release of Drugs Nano 2007, 2, 115-120 10.1142/S1793292007000441
53. Yuan, P.; Southon, P. D.; Liu, Z.; Green, M. E.; Hook, J. M.; Antill, S. J.; Kepert, C. J. Functionalization of Halloysite Clay Nanotubes by Grafting with -Aminopropyltriethoxysilane J. Phys. Chem. C 2008, 112, 15742-15751 10.1021/jp805657t
54. Kumar, A. V.; Varadaraj, M. C.; Lalitha, R. G.; Tharanathan, R. N. Low Molecular Weight Chitosans: Preparation with the Aid of Papain and Characterization Biochim. Biophys. Acta, Gen. Subj. 2004, 1670, 137-146 10.1016/j.bbagen.2003.11.004
55. Li, C.; Liu, J.; Qu, X.; Guo, B.; Yang, Z. Polymer-Modified Halloysite Composite Nanotubes J. Appl. Polym. Sci. 2008, 110, 3638-3646 10.1002/app.28879
56. Mu, B.; Zhao, M.; Liu, P. Halloysite Nanotubes Grafted Hyperbranched (co) Polymers Via Surface-Initiated Self-Condensing Vinyl (co) Polymerization J. Nanopart. Res. 2008, 10, 831-838 10.1007/s11051-007-9319-2
57. Liu, M.; Guo, B.; Du, M.; Cai, X.; Jia, D. Properties of Halloysite Nanotube-Epoxy Resin Hybrids and the Interfacial Reactions in the Systems Nanotechnology 2007, 18, 455703 10.1088/0957-4484/18/45/455703
58. Sato, Y.; Yokoyama, A.; Shibata, K.-i.; Akimoto, Y.; Ogino, S.-I.; Nodasaka, Y.; Kohgo, T.; Tamura, K.; Akasaka, T.; Uo, M. et al. Influence of Length on Cytotoxicity of Multi-Walled Carbon Nanotubes against Human Acute Monocytic Leukemia Cell Line THP-1 in Vitro and Subcutaneous Tissue of Rats in Vivo Mol. BioSyst. 2005, 1, 176-182 10.1039/b502429c
59. Guan, S.; Liang, R.; Li, C.; Yan, D.; Wei, M.; Evans, D. G.; Duan, X. A Layered Drug Nanovehicle toward Targeted Cancer Imaging and Therapy J. Mater. Chem. B 2016, 4, 1331-1336 10.1039/C5TB02521D
60. Ritger, P. L.; Peppas, N. A. A Simple Equation for Description of Solute Release I. Fickian and Non-Fickian Release from Non-Swellable Devices in the Form of Slabs, Spheres, Cylinders or Discs J. Controlled Release 1987, 5, 23-36 10.1016/0168-3659(87)90034-4
61. Liu, H.-Y.; Du, L.; Zhao, Y.-T.; Tian, W.-Q. In Vitro Hemocompatibility and Cytotoxicity Evaluation of Halloysite Nanotubes for Biomedical Application J. Nanomater. 2015, 2015, 685323 10.1155/2015/685323
62. 2-and p53-Dependent Pathways J. Biol. Chem. 2004, 279, 25535-25543 10.1074/jbc.M400944200
63. Wang, X.; Song, Y.; Ren, J.; Qu, X. Knocking-Down Cyclin a 2 by Sirna Suppresses Apoptosis and Switches Differentiation Pathways in K562 Cells Upon Administration with Doxorubicin PLoS One 2009, 4, e6665 10.1371/journal.pone.0006665
64. Ma, Y.-C.; Wang, J.-X.; Tao, W.; Qian, H.-S.; Yang, X.-Z. Polyphosphoester-Based Nanoparticles with Viscous Flow Core Enhanced Therapeutic Efficacy by Improved Intracellular Drug Release ACS Appl. Mater. Interfaces 2014, 6, 16174-16181 10.1021/am5042466
65. Ma, Y.-C.; Wang, J.-X.; Tao, W.; Sun, C.-Y.; Wang, Y.-C.; Li, D.-D.; Fan, F.; Qian, H.-S.; Yang, X.-Z. Redox-Responsive Polyphosphoester-Based Micellar Nanomedicines for Overriding Chemoresistance in Breast Cancer Cells ACS Appl. Mater. Interfaces 2015, 7, 26315-26325 10.1021/acsami.5b09195
66. Mo, J.; He, L.; Ma, B.; Chen, T. Tailoring Particle Size of Mesoporous Silica Nanosystem to Antagonize Glioblastoma and Overcome Blood-Brain Barrier ACS Appl. Mater. Interfaces 2016, 8, 6811-6825 10.1021/acsami.5b11730
67. Liu, Y.; Luo, Y.; Li, X.; Zheng, W.; Chen, T. Rational Design of Selenadiazole Derivatives to Antagonize Hyperglycemia-Induced Drug Resistance in Cancer Cells Chem.-Asian J. 2015, 10, 642-652 10.1002/asia.201403409
68. Hamanaka, R. B.; Chandel, N. S. Mitochondrial Reactive Oxygen Species Regulate Cellular Signaling and Dictate Biological Outcomes Trends Biochem. Sci. 2010, 35, 505-513 10.1016/j.tibs.2010.04.002
69. Pieczenik, S. R.; Neustadt, J. Mitochondrial Dysfunction and Molecular Pathways of Disease Exp. Mol. Pathol. 2007, 83, 84-92 10.1016/j.yexmp.2006.09.008
70. Bras, M.; Queenan, B.; Susin, S. Programmed Cell Death Via Mitochondria: Different Modes of Dying Biochemistry (Moscow) 2005, 70, 231-239 10.1007/s10541-005-0105-4